U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855862) titled 'An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of Vedolizumab' on Feb. 24.

Brief Summary: It is uncertain the relationship between serum cytokine levels and the clinical efficacy of vedolizumab in the treatment of ulcerative colitis. The effects of cytokines on the efficacy of vidrecizumab in Chinese UC patients were retrospectively analyzed. Methods: Patients with UC were recorded. These patients were detected the levels of cytokines.

Study Start Date: Nov. 05, 2020

Study Type: OBSERVATIONAL

Condition: Ulcerative Colitis (UC)

Recruitment Status: COMPLETED

Sponsor: Second Affiliated ...